Plasma DNMT1 Activity for Assessing Tumor Burden and Predicting Neoadjuvant Therapy Response in Breast Cancer (Adv. Sci. 31/2025)

Plasma DNMT1 Activity The cover depict a sensitive method for detecting DNA methyltransferase 1 (DNMT1) in human plasma, namely DNMT1 identification by variable activity (DIVA). The high sensitivity of this method enables effective tumor burden assessment and neoadjuvant therapy prediction for breast cancer patients. More details can be found in article number 2501064 by Ming Chen, Xiaowei Qi, Mingxuan Gao, and co-workers.